Eloxx Pharmaceuticals Correlations
| ELOXDelisted Stock | USD 3.82 0.23 5.68% |
The correlation of Eloxx Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eloxx Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eloxx Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. Eloxx |
The ability to find closely correlated positions to Eloxx Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eloxx Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eloxx Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eloxx Pharmaceuticals to buy it.
Moving together with Eloxx Pink Sheet
| 0.79 | KA | Kineta Inc Financial Report 9th of May 2024 | PairCorr |
| 0.65 | VCNX | Vaccinex | PairCorr |
| 0.82 | VCYT | Veracyte Financial Report 2nd of May 2024 | PairCorr |
| 0.66 | DRMA | Dermata Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.73 | DRUG | Bright Minds Biosciences | PairCorr |
| 0.75 | DRTS | Alpha Tau Medical Financial Report 28th of May 2024 | PairCorr |
Moving against Eloxx Pink Sheet
| 0.78 | VKTX | Viking Therapeutics | PairCorr |
| 0.68 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.67 | VERU | Veru Inc Financial Report 9th of May 2024 | PairCorr |
| 0.67 | VIRX | Viracta Therapeutics Financial Report 13th of May 2024 | PairCorr |
| 0.64 | YS | YS Biopharma | PairCorr |
| 0.62 | VANI | Vivani Medical | PairCorr |
| 0.48 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
| 0.47 | VERA | Vera Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.46 | DOMH | Dominari Holdings | PairCorr |
| 0.43 | DNTH | Dianthus Therapeutics Symbol Change | PairCorr |
| 0.42 | DYAI | Dyadic International Financial Report 8th of May 2024 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Eloxx Pink Sheet performing well and Eloxx Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eloxx Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| ZURA | 5.08 | 0.37 | 0.05 | 0.51 | 6.60 | 17.07 | 42.14 | |||
| CYTO | 4.82 | (0.27) | 0.00 | (0.18) | 0.00 | 11.11 | 47.75 | |||
| IMMX | 4.65 | (1.22) | 0.00 | (0.35) | 0.00 | 8.22 | 25.10 | |||
| ENVB | 6.32 | 0.40 | 0.08 | 0.28 | 5.24 | 15.29 | 86.10 | |||
| PALI | 6.60 | 0.15 | 0.04 | 0.12 | 9.13 | 11.30 | 119.62 | |||
| SGTX | 14.23 | 7.20 | 0.77 | (0.41) | 5.55 | 11.95 | 442.39 | |||
| RVPH | 3.25 | (0.29) | 0.00 | 3.72 | 0.00 | 7.31 | 32.56 | |||
| ZVSA | 4.99 | (0.20) | 0.00 | (0.08) | 0.00 | 10.00 | 45.41 | |||
| KRBP | 3.59 | (0.99) | 0.00 | (2.81) | 0.00 | 6.78 | 24.57 | |||
| UNCY | 4.58 | 0.14 | 0.04 | 0.18 | 4.38 | 10.53 | 24.66 |
View Eloxx Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Eloxx Pharmaceuticals Corporate Directors
Eloxx Pharmaceuticals corporate directors refer to members of an Eloxx Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Eloxx Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Eloxx Pharmaceuticals' board members must vote for the resolution. The Eloxx Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Ran Nussbaum | Director | Profile | |
| Tomer Kariv | Director | Profile | |
| Steven Rubin | Director | Profile | |
| Zafrira Avnur | Director | Profile |
Still Interested in Eloxx Pharmaceuticals?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in Eloxx Pink Sheet
If you are still planning to invest in Eloxx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Eloxx Pharmaceuticals' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |